FOXM1 and colorectal carcinoma: As shown in Figure 4A and 4B, a difference in tumor growth was observed between FOXM1 overexpressing and control CRC cells, whereas the difference was more significant upon 5-FU treatment, indicating that FOXM1 conferred 5-FU tolerance to CRC cells.